These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16115486)

  • 21. Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations.
    Holleboom AG; Daniil G; Fu X; Zhang R; Hovingh GK; Schimmel AW; Kastelein JJ; Stroes ES; Witztum JL; Hutten BA; Tsimikas S; Hazen SL; Chroni A; Kuivenhoven JA
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3066-75. PubMed ID: 23023370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy.
    Dimick SM; Sallee B; Asztalos BF; Pritchard PH; Frohlich J; Schaefer EJ
    J Clin Lipidol; 2014; 8(2):223-30. PubMed ID: 24636183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism.
    Karuna R; Holleboom AG; Motazacker MM; Kuivenhoven JA; Frikke-Schmidt R; Tybjaerg-Hansen A; Georgopoulos S; van Eck M; van Berkel TJ; von Eckardstein A; Rentsch KM
    Atherosclerosis; 2011 Feb; 214(2):448-55. PubMed ID: 21130455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two novel point mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in LCAT deficiency: LCAT (G873 deletion) and LCAT (Gly344-->Ser).
    Moriyama K; Sasaki J; Arakawa F; Takami N; Maeda E; Matsunaga A; Takada Y; Midorikawa K; Yanase T; Yoshino G
    J Lipid Res; 1995 Nov; 36(11):2329-43. PubMed ID: 8656071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lecithin:cholesterol acyltransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate.
    Albers JJ; Chen CH; Adolphson JL
    J Lipid Res; 1981 Nov; 22(8):1206-13. PubMed ID: 7320631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesterol esterification by lecithin-cholesterol acyltransferase in A-I-free plasma.
    Cheung MC; Wang DB; Lum KD; Albers JJ
    Biochim Biophys Acta; 1988 Sep; 962(2):258-64. PubMed ID: 3139041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
    Simonelli S; Tinti C; Salvini L; Tinti L; Ossoli A; Vitali C; Sousa V; Orsini G; Nolli ML; Franceschini G; Calabresi L
    Biologicals; 2013 Nov; 41(6):446-9. PubMed ID: 24140107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of plasma cholesterol esterification by sphingomyelin: effect of physiological variations of plasma sphingomyelin on lecithin-cholesterol acyltransferase activity.
    Subbaiah PV; Jiang XC; Belikova NA; Aizezi B; Huang ZH; Reardon CA
    Biochim Biophys Acta; 2012 Jun; 1821(6):908-13. PubMed ID: 22370449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased esterification of cholesterol and transfer of cholesteryl ester to apo B-containing lipoproteins in Type 2 diabetes: relationship to serum lipoproteins A-I and A-II.
    Jones RJ; Owens D; Brennan C; Collins PB; Johnson AH; Tomkin GH
    Atherosclerosis; 1996 Jan; 119(2):151-7. PubMed ID: 8808492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two different allelic mutations in a Finnish family with lecithin:cholesterol acyltransferase deficiency.
    Miettinen H; Gylling H; Ulmanen I; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):460-7. PubMed ID: 7749857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential gene therapy for lecithin-cholesterol acyltransferase (LCAT)-deficient and hypoalphalipoproteinemic patients with adenovirus-mediated transfer of human LCAT gene.
    Séguret-Macé S; Latta-Mahieu M; Castro G; Luc G; Fruchart JC; Rubin E; Denèfle P; Duverger N
    Circulation; 1996 Nov; 94(9):2177-84. PubMed ID: 8901669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two novel molecular defects in the LCAT gene are associated with fish eye disease.
    Kuivenhoven JA; Stalenhoef AF; Hill JS; Demacker PN; Errami A; Kastelein JJ; Pritchard PH
    Arterioscler Thromb Vasc Biol; 1996 Feb; 16(2):294-303. PubMed ID: 8620346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea.
    Flores R; Jin X; Chang J; Zhang C; Cogan DG; Schaefer EJ; Kruth HS
    Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31779197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.
    Hörl G; Kroisel PM; Wagner E; Tiran B; Petek E; Steyrer E
    Atherosclerosis; 2006 Jul; 187(1):101-9. PubMed ID: 16216249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency.
    Nanjee MN; Cooke CJ; Olszewski WL; Miller NE
    J Lipid Res; 2000 Aug; 41(8):1317-27. PubMed ID: 10946020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Premature and severe cardiovascular disease in a Mexican male with markedly low high-density-lipoprotein-cholesterol levels and a mutation in the lecithin:cholesterol acyltransferase gene: a family study.
    Posadas-Sánchez R; Posadas-Romero C; Ocampo-Arcos WA; Villarreal-Molina MT; Vargas-Alarcón G; Antúnez-Argüelles E; Mendoza-Pérez E; Cardoso-Saldaña G; Martínez-Alvarado R; Medina-Urrutia A; Jorge-Galarza E
    Int J Mol Med; 2014 Jun; 33(6):1570-6. PubMed ID: 24715031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inherited disorders of HDL metabolism and atherosclerosis.
    Hovingh GK; de Groot E; van der Steeg W; Boekholdt SM; Hutten BA; Kuivenhoven JA; Kastelein JJ
    Curr Opin Lipidol; 2005 Apr; 16(2):139-45. PubMed ID: 15767853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different substrate specificities of plasma lecithin: cholesterol acyl transferase in fish eye disease and Tangier disease.
    Carlson LA; Holmquist L; Assmann G
    Acta Med Scand; 1987; 222(4):345-50. PubMed ID: 3425387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A normal rate of cellular cholesterol removal can be mediated by plasma from a patient with familial lecithin-cholesterol acyltransferase (LCAT) deficiency.
    Bérard AM; Clerc M; Brewer B; Santamarina-Fojo S
    Clin Chim Acta; 2001 Dec; 314(1-2):131-9. PubMed ID: 11718688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.
    Calabresi L; Simonelli S; Conca P; Busnach G; Cabibbe M; Gesualdo L; Gigante M; Penco S; Veglia F; Franceschini G
    J Intern Med; 2015 May; 277(5):552-61. PubMed ID: 25039266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.